(PharmaNewsWire.Com, August 17, 2017 ) Rising aged population, technological advancement in bio-implants, high level of healthcare awareness and rising disposable incomes are the factors driving the non-surgical bio-implants market. However, high treatment cost, increasing application areas mostly medical and aesthetic for biomaterials used in non-surgical bio-implants and reimbursement issues are the factors hindering the market. Collagen based bio-implants holds major share owing to its lower cost and easy availability. North America region has the major market for non-surgical bio-implants in terms of revenue owing to huge number of key players and strong healthcare infrastructure. Europe region is the second leading non-surgical bio-implants market due to technical advancements in the region.
Regions Covered: - North America - US - Canada - Mexico - Europe - Germany - France - Italy - UK - Spain - Rest of Europe - Asia Pacific - Japan - China - India - Australia - New Zealand - Rest of Asia Pacific - Rest of the World - Middle East - Brazil - Argentina - South Africa - Egypt
8 Company Profiling 8.1 Novatex Bioengineering SA 8.2 LCA Pharmaceuticals 8.3 Moma Therapeutics, Inc. 8.4 Johnson & Johnson 8.5 Kythera Pharmaceuticals, Inc. 8.6 Anika Therapeutics, Inc. 8.7 Fidia Farmaceutici 8.8 FibroGen, Inc. 8.9 Hangzhou Gallop Biological Products Co. Ltd. 8.10 Albiorex International 8.11 BioPolymer GmbH & Co. KG 8.12 Adoderm 8.13 Nordic Aesthetics 8.14 Teoxane Laboratoires 8.15 Coapt Systems
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
